WALNUT CREEK, Calif. - February 14, 2022 - (Newswire.com) Vivacitas Oncology, Inc., a privately-held biopharmaceutical company focused on tough-to-treat cancers, will present at the upcoming 2022 BIO CEO & Investor Conference, which will be held in New York City on February 14-1...
Related Keywords
New York , United States , Walnut Creek , Mark Suseck , Joseph Rubinfeld , Amgen , Marriott Marquis , Vivacitas Oncology Inc , International Convention , Biotechnology Innovation Organization , New York City , Vivacitas Oncology , Executive Team , Release Service ,
vimarsana.com © 2020. All Rights Reserved.